GI
AGN

Glovista Investments’s Allergan plc AGN Stock Holding History

Glovista Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,915
Closed -$555K – 111
2018
Q3 		$555K Hold
2,915
– – 0.14% 68
2018
Q2 		$486K Hold
2,915
– – 0.12% 78
2018
Q1 		$491K Sell
2,915
-150
-5% -$25.2K 0.11% 62
2017
Q4 		$501K Buy
3,065
+250
+9% +$44.9K 0.1% 66
2017
Q3 		$577K Sell
2,815
-50
-2% -$11.6K 0.11% 73
2017
Q2 		$696K Hold
2,865
– – 0.15% 67
2017
Q1 		$685K Buy
+2,865
New +$667K 0.15% 72

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Glovista Investments's AGN Position: Q4 2018 in Review

Glovista Investments sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 2,915 shares — an estimated $555K sold.

Glovista Investments first reported a position in AGN in Q1 2017 and held it in 7 quarters. The position peaked at $696K in Q2 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Glovista Investments reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Glovista Investments sold 2,915 Allergan plc shares in Q4 2018, an estimated $555K.
  • Glovista Investments first reported a position in Allergan plc in Q1 2017 and held it in 7 quarters.
  • Glovista Investments's Allergan plc position peaked at $696K in Q2 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Glovista Investments's 13F filing for Q4 2018, filed 13 Feb 2019.